| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e0bf0928b608797b70bbc2b91c7e52e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522 |
| filingDate |
2010-02-19^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68fd8607247075649319fdf87e06b1a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_468dd956d67141c50b3d79f2a4613d4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56812cb55e74ea6c54bf648615376a3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1af33875619046754f3e3354028e964a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_860b563aec73bc4c935851c9ab8ecef0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2650562e5de824027a60c0bc162c799e |
| publicationDate |
2011-12-05^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20110130440-A |
| titleOfInvention |
Compositions, Uses, and Methods of Use of Surface Active Proteins in Topical Drug Delivery Via Keratin |
| abstract |
The present invention provides the use of surface active proteins, in particular class I and class II hydrophobins, in topically applied pharmaceutical formulations. The invention particularly relates to patients (including animals and humans) for the treatment of one or more of various diseases or disorders. A topically applied pharmaceutical product for enhancing penetration to deliver a prophylactic and / or therapeutically effective amount of an active ingredient (drug) to and / or via nails of an animal or human body. |
| priorityDate |
2009-02-26^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |